Phenotel Supportive Literature

  1. Fudin J, Atkinson TJ. Personalized Oxycodone Dosing: Using Pharmacogenetic Testing and Clinical Pharmacokinetics to Reduce Toxicity Risk and Increase Effectiveness. Editorial. Pain Medicine. May 2014. 15(5):723–725.
  2. Janicki PK. Pharmacogenomics of Pain Management. In Comprehensive Treatment of Chronic Pain by Medical, Interventional, and Integrative Approaches. Deer TR. et al. (eds.), American Academy of Pain Medicine 2013:23-33.
  3. Owusu-Obeng A, Weitzel KW,4 Hatton RC, Staley BJ, Ashton J, Cooper-Dehoff RM, Johnson JA. Emerging Roles for Pharmacists in Clinical Implementation of Pharmacogenomics. Pharmacotherapy. 2014. 34(10): 1102-12.
  4. Flockhart DA, Lu WJ. Pharmacogenetics: Personalizing Pain Medicine. Supplement in Practical Pain Management. 2014 September; 14(8):49-57.
  5. Vuilleumier PH, Stamer UM, Landau R. Pharmacogenomic considerations in opioid analgesia. Pharmacogenomics and Personalized Medicine. 2012:5 73–87.
  6. Linares O, Michel T, Fudin J, Boston RC, Daly AM. Letter to the editor in Pain Physician. Integrating Clinical Pharmacokinetics, Pharmacogenetics, and Quantitative Cytochrome P450 Polymorphic Gene Drug-Drug Interactions (DDIs). Pain Physician. 2015; In press.